• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Ironwood Pharmaceuticals

Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Cue lines up new CMO and research head—Chutes & Ladders

Cue lines up new CMO and research head. ProFound picks Little as new COO. Elevara elects former IO chief as new leader.
Darren Incorvaia , Zoey Becker , Will Maddox , Marissa Russo Jul 17, 2026 8:30am
FDA stop sign

Ironwood mulls options after FDA demands further GI drug study

Apr 14, 2025 10:51am
Stock exchange concept

Ironwood makes further bid for $1B GI drug with subgroup data

Oct 28, 2024 12:33pm
starry star gazing galaxy constellations

Ironwood spies new frontier for $1B drug in exploratory trial

Mar 28, 2024 9:00am
sales decline revenue decline sales revenue stock stock market

Ironwood seeing STARS as phase 3 hit triggers 30% stock drop

Feb 29, 2024 7:52am
Tree lightning storm thunder

Ironwood pays $1B for VectivBio and its phase 3 GI drug

May 22, 2023 10:05am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings